These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1186087)
41. [Effectiveness of the use of immunosuppressive agents in the treatment of chronic hepatitis and liver cirrhosis]. Vakulenko EF Vrach Delo; 1975 Sep; (9):55-6. PubMed ID: 1210301 [No Abstract] [Full Text] [Related]
42. [Significance of serum carnitine in patients with liver diseases]. Lin XH; Jiao LL; Xu GB; Tian GS Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):367-9. PubMed ID: 16732913 [TBL] [Abstract][Full Text] [Related]
43. [Mesenchyma-suppressing therapy of chronic aggressive hepatitis]. Gros H; Zwirner K; Herzog W Med Klin; 1972 Oct; 67(40):1277-82. PubMed ID: 4638147 [No Abstract] [Full Text] [Related]
44. [Effect of anabolic steroids on protein metabolism under various protein administrations in chronic liver disease patients]. Blahníková L; Horký J Z Ernahrungswiss Suppl; 1972; 13():105-12. PubMed ID: 4510113 [No Abstract] [Full Text] [Related]
45. [Phagocytic activity of the leukocytes in chronic bronchitis]. Osipov IuA Sov Med; 1984; (1):17-21. PubMed ID: 6701647 [No Abstract] [Full Text] [Related]
46. [Study of total insulin activity and the content of free insulin in the blood in chronic diffuse liver diseases]. Rostomova LT; Kurashvili RB Ter Arkh; 1974; 46(12):87-90. PubMed ID: 4454029 [No Abstract] [Full Text] [Related]
47. [Clinical studies on the effectiveness of Xantinol-nicotinate in chronic hepatitis and liver cirrhosis]. Dohrmann RE; Konrad D; Sawade H; Kühl I Med Klin; 1968 Nov; 63(44):1772-6. PubMed ID: 5704508 [No Abstract] [Full Text] [Related]
48. [Treatment of chronic active hepatitis by 6-mercaptopurine and immuran (azathioprine)]. Aprosina ZG; Mukhin AS Sov Med; 1972 Feb; 35(2):94-7. PubMed ID: 5039432 [No Abstract] [Full Text] [Related]
50. [Long term therapy of chronic progressive (aggressive) hepatitis using a combination of imuran and prednisone]. Schimmelpfennig W; Wagner K; Theuer D; Schneider G; Hecht A; Schimmelpfennig R Dtsch Gesundheitsw; 1971 Oct; 26(42):1965-71. PubMed ID: 5004132 [No Abstract] [Full Text] [Related]
51. [Leukocyte intracellular metabolism and phagocytic activity in patients with an erysipelatous inflammation]. Nagoev BS; Kanukoeva MIu Ter Arkh; 1990; 62(11):50-3. PubMed ID: 2094990 [TBL] [Abstract][Full Text] [Related]
52. [Anemic syndrome in chronic hepatitis and liver cirrhosis]. Korolko IuR; Sarycheva TG; Kotelńikov VM; Kozinets GI; Zherebtsov LA Klin Med (Mosk); 1993; 71(5):45-8. PubMed ID: 8301986 [TBL] [Abstract][Full Text] [Related]
53. [Treatment of chronic liver diseases with thioctic acid]. Möller E; Brinkmann W; Weber O; Wildhirt E Med Klin; 1967 Mar; 62(10):380-4. PubMed ID: 4874626 [No Abstract] [Full Text] [Related]
54. [The effect of prednisolone on the blood coagulation system in chronic hepatitis]. Krutovskaia OV Klin Med (Mosk); 1967 Aug; 45(8):70-3. PubMed ID: 5610475 [No Abstract] [Full Text] [Related]
55. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions]. Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451 [No Abstract] [Full Text] [Related]